Literature DB >> 18789737

Course, complications, and outcome of juvenile arthritis-related uveitis.

Kourosh Sabri1, Rotraud K Saurenmann, Earl D Silverman, Alex V Levin.   

Abstract

PURPOSE: To describe the clinical features of uveitis in patients with juvenile idiopathic arthritis (JIA).
METHODS: Retrospective chart review of a subset of 1,081 consecutive JIA patients who were younger than 18 years of age and had uveitis, with a minimum of 1-year follow-up at a single center.
RESULTS: One hundred forty-two patients (13.1%) developed uveitis after a mean follow-up of 6.3 years (range, 0.10-23.2). Uveitis types were chronic anterior (97/142, 68.3%), acute anterior (23/142, 16.2%), recurrent anterior (17/142, 12%), and panuveitis (5/142, 3.5%). Uveitic complications were observed in 37.3% of cases (53/142) and 32.5% of eyes (74/228). When we compared uveitic eyes with complications to uveitic eyes without complications, we found the following significant differences: time interval from diagnosis of JIA to diagnosis of uveitis was shorter (mean, 1.3 years vs. 2.2 years; p = 0.003) and use of oral prednisone was greater (59.1% vs 15.6%; p < 0.0001) in the eyes with complications. Twenty-one children (21/142, 14.8%) with uveitis underwent a total of 62 ocular surgeries. Good visual acuity (20/40 or better) was found in 90.8% of eyes (159/175) and in both eyes of 87% of cases (94/108), impaired visual acuity in 6 eyes of 4 cases (6/175, 3.4%), and blindness in 10 eyes of 10 cases (10/175, 5.7%). Only 2 patients had reduced visual acuity in both eyes. Surgery was the single most important risk factor for reduced visual acuity at the last follow-up (p = 0.0086).
CONCLUSIONS: Most uveitic eyes with JIA achieved good visual outcome despite uveitic complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789737     DOI: 10.1016/j.jaapos.2008.03.007

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  36 in total

Review 1.  Emerging role of antioxidants in the protection of uveitis complications.

Authors:  U C S Yadav; N M Kalariya; K V Ramana
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  Leflunomide, a valid and safe drug for the treatment of chronic anterior uveitis associated with juvenile idiopathic arthritis.

Authors:  Clara Molina; Consuelo Modesto; Nieves Martín-Begué; Cristina Arnal
Journal:  Clin Rheumatol       Date:  2013-07-05       Impact factor: 2.980

Review 3.  Optical coherence tomography imaging in uveitis.

Authors:  Sumru Onal; Ilknur Tugal-Tutkun; Piergiorgio Neri; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2013-07-09       Impact factor: 2.031

Review 4.  The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.

Authors:  Melissa A Lerman; C Egla Rabinovich
Journal:  Paediatr Drugs       Date:  2015-08       Impact factor: 3.022

Review 5.  Uveitis associated with juvenile idiopathic arthritis.

Authors:  Ethan S Sen; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Nat Rev Rheumatol       Date:  2015-03-31       Impact factor: 20.543

Review 6.  Prevention and management of cataracts in children with juvenile idiopathic arthritis-associated uveitis.

Authors:  Sheila Angeles-Han; Steven Yeh
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

Review 7.  Treatment of uveitis associated with juvenile idiopathic arthritis.

Authors:  Rosa Bou; Estíbaliz Iglesias; Jordi Antón
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

8.  Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study.

Authors:  Anthony C Gregory; John H Kempen; Ebenezer Daniel; R Oktay Kaçmaz; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne
Journal:  Ophthalmology       Date:  2012-10-11       Impact factor: 12.079

9.  Burden of childhood-onset arthritis.

Authors:  Lakshmi N Moorthy; Margaret Ge Peterson; Afton L Hassett; Thomas Ja Lehman
Journal:  Pediatr Rheumatol Online J       Date:  2010-07-08       Impact factor: 3.054

Review 10.  Current perspectives on ophthalmic manifestations of childhood rheumatic diseases.

Authors:  Neal V Palejwala; Steven Yeh; Sheila T Angeles-Han
Journal:  Curr Rheumatol Rep       Date:  2013-07       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.